Cargando…

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult

Detalles Bibliográficos
Autores principales:	Ferguson, Sara B., Gallo, Elisa S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537385/ https://www.ncbi.nlm.nih.gov/pubmed/28795126 http://dx.doi.org/10.1016/j.jdcr.2017.05.007

Ejemplares similares

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series
por: BOSSART, Simon, et al.
Publicado: (2020)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
por: Pizzatti, Laura, et al.
Publicado: (2020)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Systemic 9-valent human papillomavirus vaccine for recalcitrant common cutaneous warts in preparation for renal transplant
por: Wyant, W. Austin, et al.
Publicado: (2022)

Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020)

Human papillomavirus infection with anogenital warts in a patient with chronic psoriasis: A case report
por: Hsieh, Wu‐Feng, et al.
Publicado: (2021)

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
por: Silling, Steffi, et al.
Publicado: (2014)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
por: Petry, Karl-Ulrich, et al.
Publicado: (2018)

Human Papillomavirus Genotyping in Cutaneous Warts of Koreans by Sequencing
por: Kim, Kang Su, et al.
Publicado: (2021)

Combination Treatment of Periungual Warts
por: Patidar, Sukhdeo
Publicado: (2008)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

Human papillomavirus type 7 identified in digitated warts on facial seborrhoeic eczema of a non‐butcher immunocompetent individual
por: Izumi, Yuko, et al.
Publicado: (2022)

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
por: De La Fuente, Jesús, et al.
Publicado: (2019)

Characteristics of human papillomaviruses infection in men with genital warts in Shanghai
por: Chen, Xiaogang, et al.
Publicado: (2016)

Determinants of high-risk human papillomavirus infection in anogenital warts
por: Ozaydin-Yavuz, Goknur, et al.
Publicado: (2019)

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
por: Bosco, Liana, et al.
Publicado: (2021)

Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
por: Xu, Hui, et al.
Publicado: (2019)

Wide Spectrum Analysis of Human Papillomavirus Genotypes in External Anogenital Warts
por: Rideg, Orsolya, et al.
Publicado: (2021)

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males: Profile Report
por: Garnock-Jones, Karly P., et al.
Publicado: (2012)

Treatment of Gonorrhœa and Syphilitic Warts
por: Hamilton, J. B.
Publicado: (1868)

Topical vitamin A treatment of recalcitrant common warts
por: Gaston, Anca, et al.
Publicado: (2012)

Cantharidin-Podophyllin-Salicylic Acid Formulation as a First-Line Treatment for Plantar Warts? A Case Report with Multiple Plantar Warts of Human Papillomavirus Biotype 27 and Previous Failed Treatments
por: Navarro-Pérez, David, et al.
Publicado: (2022)

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

Prevalence and Determinants of High-Risk Human Papillomavirus Infection in Male Genital Warts
por: Park, Sung Jin, et al.
Publicado: (2014)

High Frequency of Human Papillomavirus Genotype 16 Among Patients With Anogenital Warts
por: Yaghoobi, Reza, et al.
Publicado: (2015)

Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women
por: Dareng, Eileen O., et al.
Publicado: (2019)

Global gene methylation profiling of common warts caused by human papillomaviruses infection
por: Alghamdi, Mansour A., et al.
Publicado: (2021)

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination
por: Shing, Jaimie Z., et al.
Publicado: (2019)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

2013 Trends in anogenital warts incidence: Potential impact of human papillomavirus vaccination, TennCare 2006–2015
por: Shing, Jaimie Z., et al.
Publicado: (2018)

An Improved Protocol for Comprehensive Etiological Characterization of Skin Warts and Determining Causative Human Papillomavirus Types in 128 Histologically Confirmed Common Warts
por: Skubic, Lucijan, et al.
Publicado: (2022)

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study
por: Gilca, Vladimir, et al.
Publicado: (2018)

Insects are Crawling in My Genital Warts
por: Dhawan, Jyoti, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oinfl9mj3vumdfoj3dv8uqkqkp